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Background: Preterm infants are especially vulnerable to dysbiosis since their early gut microbiota is less 
abundant and diverse. When the first microbial colonizers reach infants’ gut remains an open question. It is 
assumed that maternal microbiota can influence the infants’ gut colonization, making it a critical player in the 
offspring’s immune and endocrine systems, as well as in metabolic health. Infant feeding has been reported 
as a major factor influencing the gut microbiota. Thus, studying the preterm infant gut microbiota is a research 
priority to complement nutritional neonatal care.  
Objective: The aim of this study was to evaluate the influence of different types of infant-feeding on the gut 
microbiota preterm infants. In addition, it was evaluated the preterm infants’ meconium colonization and the 
influence of vertical microbiota transmission. 
Methodology: The FEEDMI Trial is an observational longitudinal study that included very preterm infants (≤ 32 
weeks of gestational age), hospitalized in the neonatal intensive care unit of Maternidade Dr. Alfredo da Costa.  
A total of four meconium and fecal samples from preterm infants were collected. Mothers were also asked to 
collect their fecal samples. Bacterial DNA present was extracted from samples and specific bacterial groups 
were quantified by RT-PCR. 
Results: In total, 453 fecal samples were processed from 117 preterm infants and their mothers. 88% of 
meconium samples were colonized. Proteobacteria and Firmicutes were the most abundant phyla during the 
first 26th postnatal days of infants. Meconium microbiota of preterm infants born between 28 and 32 weeks 
gestation showed stronger correlations with their mothers’ microbiota, as well as infants born by cesarean. 
Maternal factors significantly influenced the offspring’s microbiota, specially the pre-gestational body mass 
index. Mode of delivery had a limited impact on infants’ meconium with C-section promoting a greater amount 
of E. coli. Infant feeding takes time to influence the gut microbiota of preterm infants. When adjusted for 
gestational age, antibiotherapy and maternal diet, mothers’ own milk (MOM) promoted a healthier gut 
microbiota with higher levels of total bacteria and Bifidobacterium compared to donor human milk (DHM) and 
formula. Nevertheless, these differences were lower in DHM than formula fed infants.  It was also observed 
lower levels of Firmicutes in infants fed with formula after adjusting for the same factors. 
Conclusions: The findings of this thesis suggest that infants’ meconium may have bacterial DNA prior to birth 
and maternal factors may have a central role in this process. Furthermore, this thesis highlights the importance 
of human milk on gut microbiota composition of infants prematurely-delivered with MOM promoting higher 
levels of total bacteria and Bifidobacterium, which may be translated in future healthier outcomes. 
Key-words: breast milk, donor human milk, formula, intestinal microbiota, maternal factors, preterm infants  




Introdução: Os bebés prematuros são especialmente vulneráveis a disbiose intestinal, uma vez que o seu 
microbiota é pouco abundante e diverso. O momento em que os primeiros microrganismos colonizam o 
intestino do recém-nascido é uma questão em aberto. Sabe-se que o microbiota materno pode influenciar a 
colonização do intestino dos bebés, tendo um papel crucial no desenvolvimento dos sistemas imunitário e 
endócrino, assim como na saúde metabólica dos mesmos. A alimentação tem sido descrita como um dos 
fatores mais importantes que influencia o microbiota da criança. Neste sentido, estudar o microbiota intestinal 
de bebés prematuros é uma prioridade para complementar os cuidados alimentares neonatais.  
Objetivo: O objetivo deste estudo foi avaliar a influência dos diferentes tipos de alimentação infantil no 
microbiota intestinal de bebés prematuros. Mais ainda, foi analisada a colonização microbiana do mecónio 
destes bebés e a influência da transmissão vertical.  
Metodologia: O FEEDMI é um estudo observacional e longitudinal que inclui bebés muito prematuros (≤ 32 
semanas de gestação) hospitalizados nos cuidados intensivos neonatais da Maternidade Dr. Alfredo da Costa. 
Foram recolhidas quatro amostras de mecónio e fezes de bebés prematuros. Às mães também foi pedido que 
fizessem uma recolha das suas fezes e que respondessem a um questionário de frequência alimentar. O ADN 
bacteriano foi extraído das amostras e grupos específicos de bactérias foram quantificados por RT-PCR.  
Resultados: No total, foram processadas 453 amostras fecais de 117 bebés prematuros e das suas mães. 88% 
das amostras de mecónio estavam colonizadas. Proteobacteria e Firmicutes foram os filos mais abundantes 
durante os primeiros 26 dias. O microbiota do mecónio de bebés nascidos entre as 28 e 32 mostrou ter 
correlações mais fortes com o microbiota das suas mães, assim com nos bebés nascidos por cesariana. A via 
de parto teve um efeito reduzido no mecónio dos bebés, sendo que a cesariana promoveu quantidades mais 
elevadas de E. coli. A influência da alimentação infantil no microbiota dos bebés prematuros não é imediata. 
Quando ajustado para idade gestacional, antibioterapia e dieta materna, o leite da própria mãe (LPM) 
promoveu um microbiota intestinal mais saudável com quantidades mais elevadas de bactérias totais e 
Bifidobacterium, quando comparado com o leite de dadora (LD) e formula. Contudo, estas diferenças foram 
inferiores nos prematuros alimentados com LD do que com formula. Também foram observados quantidades 
inferiores de Firmicutes nos bebés alimentados com fórmula, quando ajustado para os mesmos fatores. 
Conclusão: Os resultados desta tese sugerem que o mecónio poderá ter ADN bacteriano antes do nascimento 
e fatores maternos podem ter um papel central neste processo. Mais ainda, esta tese evidência a importância 
do LPM na composição do microbiota intestinal de bebés nascidos prematuramente. 
Palavras-chave: bebés prematuros, fatores maternos, formula, leite da própria mãe, leite de dadora, 
microbiota intestinal  
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In the XVII century, Antonie van Leewenhoek described the rod, sphere, and spiral forms and movement of 
bacteria in his oral and fecal samples [1]. It was the first description of bacteria. The culture-based techniques 
allowed the identification and classification of several microorganisms in the human body, initially associated 
with infections and diseases. Nowadays, it is known that these microorganisms form a complex symbiotic 
relationship with their host. This bacterial network, together with non-bacterial members – viruses, fungi and 
archaea, forms a complex and dynamic ecosystem designed as microbiota [2]. Advances of the non-cultured 
techniques made possible the characterization and the better understanding of the encoded genes of 
microbes (microbiome) [2] and their role in the human health. 
In the human body bacterial cells outnumber our own somatic and germ cells with an estimated count of 
3.8×1013 and 3.0×1013 cells (1:1 ratio), respectively [3]. However, when bacterial cells are compared to 
nucleated human cells (0.3×1013, non-nucleated red blood cells is not included in the calculation) the ratio will 
be about 10:1 [3]. Although the number of these human-associated microbes is very variable between 
individuals [4], the human microbiota is composed by four dominant bacterial phyla: Firmicutes, Bacteroidetes, 
Proteobacteria and Actinobacteria (Figure 1) [5]. 
Figure 1 - Bacterial phyla composition at body human sites. Adapted from Dethlefsen et al, 2007 [5] and Blum, 2017 [6]. 
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The microbes are present throughout the human body (Figure 1), mainly in the external and internal surfaces, 
such as skin, oral and nasal mucosa, conjunctiva, genital and urinary tracts [6], and even in mammary glands 
[7] and placenta [8]. But it is in the colon that inhabits the major bacterial community – the gut microbiota, 
representing one-half (0.2 kg) of the overall mass of the colon content [3]. 
Experimental and large population-scale projects focused on the potential association between gut 
microbiome and the human health and disease, such as Metagenomics of the Human Intestinal Tract 
(MetaHIT) [9] and Human Microbiome Project (HMP) [10], are essential for the understanding of this complex 
microbial ecosystem. 
 
Studying the human gut microbiota 
After the first observations of human-associated bacteria, Pasteur, Metchnikoff, Koch, Escherich, Nissle and 
other reference scientists, made great contributions in the microbiology field. However, it was only in 1940s 
with the development of methods to culture anaerobic organisms that the fascinating human-microorganism 
world has been gaining exponential interest. Nevertheless, it is not possible to culture the majority of bacterial 
species. Actually, it is estimated that only 1% of environmental bacterial are cultivated [11]. Later, the use of 
germ-free animals to study the influence of the gut microbiota on the host and, more recently, the 
development of sequencing-based approaches (non-cultured methods) provide detailed answers about the 
diversity, richness, composition and distribution of these microbes. 
Since 1990s, it is possible to assess bacterial diversity by sequencing a small subunit ribosomal RNA gene (16S 
rRNA) [12]. The 16S rRNA gene is a highly conserved phylogenetic marker present in the major bacterial groups 
presents in the human gut [12]. Using the properly primers for amplification of single or multiple regions of 
the 16S rRNA by Polymerase Chain Reaction (PCR), the marker gene sequencing is a good method to determine 
microbial phylogenies of a sample [13]. The introduction of Next Generation Sequencing (NGS) replaced the 
16S rRNA gene-based microbial profiling analysis using primers. Sequencing of the gut microbiota not only 
revealed new microbial species, but also microbial metabolic activities and how these correlate with human 
health and disease [14]. Table 1 show these and other “omics” techniques that can be used to detected and 
classify microbes, their genes, their products and clarify their functions. 
More recently, synthetic microbial communities are being developed [11]. Using mathematical models and 
engineered microbes in artificial environments it is possible to study microbial interactions with each other 
and their responses to environmental factors [11]. 
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Table 1 - Culture independent techniques for microbiome analysis and their interaction with the host by answering these 
essential questions: Who is there?; What pathways are activated?; What proteins are being produced?; How do they interact 
with the host?. Adapted from Ilhan, 2016 [15] and Méndez-García et al, 2018 [16]. 
M e t h o d  T a r g e t  T e c h n i q u e  I n f o r m a t i o n  p r o v i d e d  




Fluorescence in situ hybridization 
(FISH) 
Microbiome composition, 




16S rRNA gene amplification; Shot 
gun (whole genome) sequencing 
Amplification assembly 
What proteins are being produced? 
Proteomics Proteins 
Mass spectrometry; Nuclear 
magnetic resonance Spectrometry 
Protein identification and 
quantification 
How do they interact with the host? 
Metabolomics Metabolites 
Mass spectrometry; Nuclear 
magnetic resonance Spectrometry 
Identify and quantify secreted and 
intracellular microbial products 
and metabolites 
 
The identification of over 1000 bacterial species prove that the human gut microbiota is a dynamic and 
complex ecosystem [17]. 
 
The gut microbiota is dynamic 
Contrasting to human genome, the microbiome is plastic. During the course of life the richness and diversity 
of bacterial composition change significantly [18]. The neonatal intestine is colonized by facultative and 
aerotolerant bacteria [Proteobacteria (Enterobacteria)] that will reduce oxygen content in the intestine to 
promote the anaerobic bacteria colonization [Actinobacteria (Bifidobacterium) and Bacteroidetes 
(Bacteroides)] [19]. At three years of age it is established the adult-like composition [20]. Since the very 
beginning, the architecture and functionally of the gut microbiota is highly dependent of host-endogenous 
and host-exogenous factors providing a very individual and unique microbial composition as a “microbiome 
fingerprint” [21]. Some of these factors include gestational age, mode of delivery, diet, exercise, antibiotic 
exposure, fasting, culture traditions, geography and genetic susceptibility (Figure 2) [22]. From all, diet is 
considered the most determinant factor for the gut microbiota [23]. 
 
The gut microbiota is complex 
The human health success depends on these large and diverse host-bacteria community [2]. Actually, there 
are numerous physical and molecular mechanisms that allowed the symbiotic relationship between host and 
commensal microorganisms [24]. A successful commensal gut bacterial composition provide essential 
enzymes that digest the polysaccharides and peptides that are indigestible to human cells [24]. The role of the 
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gut microbiota in metabolism of dietary components through bacterial fermentation process results in the 
production of important and beneficial metabolites [25]. However, if there is inadequate intake of fermentable 
dietary components (such as fermentable fiber) the bacteria use alternative energy sources resulting in the 
production of metabolites that can be detrimental to human health [25]. 
Under the influence of the factors mentioned above these metabolites, such as short-chain fatty acids (SCFAs), 
trimethylamine N-oxide (TMAO), bile acids, gut hormones and others, may contribute to the regulation of 
human metabolism and immune system development and function and, consequently, to the host health or 
disease (Figure 2) [22,25]. Indeed, an imbalance in the composition, stability and resilience of gut microbiota 
(dysbiosis) is associated to the etiology and development of many diseases involving not only the 
gastrointestinal tract, but also other distal organs (Figure 2) [26].  
Figure 2 - Contribution of both host-endogenous and host-exogenous factors on the gut microbiota. Different bacteria produce 
different metabolites that can influence the disease development in the intestine and in other distal organs, through the 
regulation of host metabolism and immune system. SCFAs, short-chain fatty acids; TMAO, trimethylamine N-oxide; BCAA, 
branched-chain amino acid; IPA, indole propionic acid; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic 
steatohepatitis; IBD, inflammatory bowel disease. The image is an adaptation of Cani et al, 2019 [23] and Levy et al, 2017 [27]. 
It is imperative to understand how microbiota can be modulated with a more personalized medicine and 
nutrition treatments in order to prevent or delay the onset of the pathologies mentioned above. Identify 
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windows of opportunity for microbiota modulation can “revolutionize our approach to healthcare” [27]. In 
fact, a special focus is being given to pregnancy and preterm birth [27]. 
 
Microbial colonization of the infant intestine 
The moment when the first microbial colonization occurs is an open question. Actually, the colonization 
process is a dogma between the “sterile womb” and “in utero colonization” hypotheses for more than 100 
years. 
Traditionally, it is accepted that vertical (maternal) and horizontal (from other persons and environment) 
transmission of microorganisms occurs only at birth, through vaginal canal and/or through contact with the 
mother’s skin microbiota immediately after birth (Figure 3a). Most studies that mentioned the uterus 
bacterial-free used cell cultured and/or microscopy methods – methods that, although still valid, have several 
limitations. These studies, many from the XX century, have shown negative results for the detection of aerobic 
and anaerobic bacteria in amniotic fluid [28–31] and meconium (the newborn’s first intestinal discharge 
comprising ingested or secreted material by the gastrointestinal tract during fetal life [32]) [33–35] of healthy 
pregnancies. However, there is no study with all samples sterile. The presence of bacteria in the amniotic fluid 
and placenta was limited to complications during pregnancy, such as premature labor, premature rupture of 
membranes and neonatal sepsis [36]. 
Later, Steel et al.  (2005) studied fetal membranes of term and preterm deliveries [37]. The membrane samples 
were collected and placed in fixative within 30 min for FISH. Bacterial DNA was detected in term deliveries 
with (46% positive samples, n = 26) or without labor (73% positive samples, n = 26), preterm deliveries with 
labor (92% positive samples, n = 13) or without labor (83% positive samples, n = 12), and preterm delivered 
with prolonged premature rupture (81% positive samples, n = 22) [37]. In the same year (2005), Jiménez et al. 
(2005) reported the presence of bacteria in umbilical cord blood healthy neonates [38]. Later, two 
independent studies conducted by Aagaard and Mysorekar, detected bacterial content in placenta samples (n 
= 320 and n = 195, respectively) of women who gave birth prematurely with and without infection and also in 
women who had term healthy pregnancy [8,39]. However, the evidence is unclear. Lauder et al. (2016) did not 
found any difference between placental samples and negative controls [40]. A recent work “confidently” 
detected bacterial rRNA in placentas of 13 from 16 spontaneous preterm births and in 18 of 22 term unlabored 
cesareans, with no significant differences between preterm and term deliveries [41]. 
Bacteria communities were also detected in amniotic fluid [42,43]. However, a more recent study with 24 
uncomplicated term pregnancies concluded that bacterial microbiota of amniotic fluid was indistinguishable 
from contaminated controls [44]. Interestingly, an Australian group wrote a critical comment about the 
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methodology used in that study [45]. The concerns raised were: sample processing, qPCR approach, and 
results analysis questioning the conclusions made [45]. 
Despite the growing evidence in favor of the hypothesis of colonization in utero, there is still no consensus 
among peers and several aspects have to be taken into consideration. A recent and exhaustive review pointed 
out several methodological limitations to studies suggesting that the microbial colonization occurs in the 
prenatal period, namely: (i) molecular techniques with an insufficient detection limit to analyze small microbial 
populations; (ii) lack of appropriate negative controls; and, (iii) lack of sterility in sample collection in 
clinical/hospital settings [36]. Another aspect to be considered is the contamination of samples by DNA 
extraction kits due to the ‘kitome’ present in the reagents and other components of the kits [46]. 
Although the placenta protects the fetus from bacterial infections, it is also the maternal-fetal communication 
organ (and not a barrier) providing oxygen, nutrients and, perhaps, bacteria or bacteria residue resulting from 
the action of antimicrobial peptides and immunoglobulins expressed in the placenta [36]. The in utero 
colonization hypothesis became stronger when animals studies suggested the maternal-fetal transfer of 
microbes. Using labeled Enterococcus faecium isolated from breast milk of healthy woman, pregnant mice 
were orally inoculated and then delivered the pups by C-section [38]. The labeled strain was detected in 
amniotic fluid [38] of these animals and in the pups’ meconium [47]. External factors, such as maternal stress 
also influenced the gut microbiota of infant monkeys, reducing the content of Lactobacillus and 
Bifidobacterium [48]. In fact, the maternal transmission of microbes is a universally shared phenomena in the 
animal kingdom [49].  
In humans, the studies are scare and the evidence is less conclusive [50]. Among 12 vaginally delivery mother-
infants, 11 presented monophyletic bifidobacterial strains indicating a vertical transmission of bacteria [51]. 
Rautava et al. (2012) administered probiotic supplementation to mothers during pregnancy and the 
Lactobacillus group were detected in all placentas specimens [52]. In addition, Toll-like receptor (TLR)-related 
gene expression was associated with bacterial DNA in amniotic fluid and placenta [52], indicating that 
maternal-fetal transfer of bacteria could influence the immune development of the offspring [50]. Recently, it 
was reported a highly shared microbial population in a large cohort of mother and their infants (n = 415) [53]. 
Mechanism by which maternal bacteria pass to the fetus are not well understood [50]. However, two 
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Figure 3 - Microbiota colonization of infants – two different hypothesis. a. Sterile womb paradigm defends that placenta and 
fetus are sterile and that gut microbiota is acquired during and after birth. Mode of delivery has been associated to transmission 
of specific bacteria: vaginal delivered promote a vagina-like microbiota in newborn and C-section leads to a bacterial 
colonization that resemble maternal skin microbiota b. The “in utero colonization hypothesis” suggests that bacterial 
colonization occurs prior to birth and it is influenced by maternal microbiota (oral cavity, gut and vagina). Two mechanism have 
been proposed to explain the mother-infant bacterial transmission: (i) the hematogenous bacterial route of bacteria from 
gastrointestinal tract (oral cavity and gut); and, (ii) ascension of bacteria from vaginal microbiota. Both routes argue that bacteria 
go into blood circulation and incorporated into the placenta decidua and, consequently, the developing fetus via amniotic fluid 
and cord blood [55]. The image is an adaptation of Perez-Muñoz et al, 2017 [37] and Milani et al, 2017 [55]. 
 
Maternal influence in offspring microbiota 
Maternal factors can disrupt the normal infants’ intestine colonization that play a critical role in the maturation 
of immune, endocrine and metabolic pathways and in development of disease later in life [54]. The prenatal 
nutrition and lifestyle are crucial for intrauterine fetal programming [55] and maternal microbial transmission 
seems to interact with biological systems being crucial for fetal health [50]. And even if this in utero 
colonization occurs only under certain circumstances (subclinical conditions), it is important to understand 
how, in order to optimize all mother, fetus and infants’ health relationships. When mothers are obese, have 
(gestational) diabetes, increased insulin resistance and increased gestational weight gain (GWG) have an 
imbalanced and an unhealthy microbiota (dysbiosis) that is directly transmitted to the offspring [56].  As review 
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by Milani (2015), alterations in the endothelial integrity of placenta may lead to an permeable barrier and, 
consequently, the passage of bacteria and endotoxins, as lipopolysaccharide (LPS), into the cord blood and 
amnion [57]. Since fetal intestine is highly sensitivity to inflammatory mediators such as LPS, it is suggested 
that maternal microbes may trigger intestinal inflammation in utero [58]. 
During pregnancy the total gut bacteria abundance was reported to decrease, as well the bacterial diversity  
between the first and third trimesters and differences were observed between normal weight and overweight 
women [59,60]. To study the impact of microbial transmission, gut microbiota samples from women in the 
third trimester were transferred to gnotobiotic mice and it was shown that mice gained more weight, became 
more insulin resistant and had higher levels of inflammatory markers [59]. Furthermore, it was found that 
children’s microbiota were most similar to their mothers’ microbiota at first trimester [59]. This was the first 
study that used high-throughput sequencing to suggest that mother-to-child microbial transmission plays a 
major role, and care should be taken not only during pregnancy but also before conception. Even if the fetus 
is developed in a sterile environmental, it has been realized that metabolites and others molecular products 
of maternal gut microbiota are part of placental molecular exchange [61]. Therefore, maternal diet exposure 
before and during pregnancy and breastfeeding can influence the gut microbiota of their infants, with long-
lasting effects [56]. 
Maternal microbiota metabolites of dietary components can reach the fetus via placenta or, after birth, 
through breast milk [61]. These molecules, or even maternal bacterial fragments, act as signals for the 
expansion of innate immune cells, development of intestinal epithelial cells and mucus, expression of 
antimicrobial peptides and secretion of antibodies into the intestinal lumen in offspring (Figure 4) [61]. In line 
with this, malnutrition (that includes deficiencies, excesses or imbalances in nutrients and/or energy intake) 
during pregnancy impairs fetal immune system through direct (for example, prolonged vitamin A deficiency 
leads to an impaired production of B lymphocytes [62]) and indirect (maternal immunosuppression decreased 
the transfer of immunoglobulins for fetus increasing the chance for infection [61]) mechanisms. 
Fetal exposure to excess blood lipids, particularly saturated fatty acids, can activate proinflammatory 
pathways, which could impact substrate metabolism and affect organ development and the response to the 
postnatal environmental factors, since the epigenetic regulation of gene expression is characterized by 
covalent modifications to DNA and chromatin that alter gene expression independent of gene sequence [63]. 
Furthermore, a prospective large cohort of 66 000 pregnant women reported that women adhering to a 
‘prudent’ (characterized for high intake of vegetables, fruit, berries, nuts, whole grains, poultry and water as 
beverage) or a ‘traditional’ (rich in boiled potatoes, vegetables, lean fish and fish products, low fat milk and 
rice pudding) dietary patterns were at lower risk of preterm delivery compared with women with a ‘Western’ 
diet (salty and sweet snacks, white bread, desserts and processed meat products) [64]. 
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Figure 4 - Maternal diet can alter the structure and function of the gut microbiota leading to an epigenetic reprogramming 
processes (DNA methylation and histone modification) during early embryogenesis. In addition, it has been suggested that exist 
bacteria in fallopian tube and in endometrium that play a key role during conception and, posteriorly, in the embryo/fetus 
development [67]. However, even considering that the intrauterine environment is sterile, it is known that maternal microbiota 
metabolize dietary components of the diet and produce molecular signals that can reach the offspring during in utero 
development via the placenta. These metabolites, as well as maternal antibodies, influence the fetus innate immune system, 
namely in the expansion of gut innate immune cells, development of intestinal epithelial cells, mucus production, expression of 
antimicrobial peptides and secretion of antibodies. An unbalanced maternal diet can result in changes on adipogenesis and 
metabolism leading to a higher susceptibility to obesity and obesity-related metabolic diseases in adult life. The image is an 
adaptation of Macpherson et al, 2017 [63] and Li, 2018 [68]. 
Mediterranean Diet (MD) – characterized by high consumption of vegetables, fruit, pulses, cereals and fish; 
using olive oil as preferential fat source (high monounsaturated:saturated fat ratio); moderate alcoholic 
beverages consumption; and, low intake of meat and meat products, milk and dairy products [65] – has been 
associated with higher birth weight and lower risk of premature birth [66]. Moreover, MD adherence during 
pregnancy seems to have a protective role in fetus against the development of Metabolic Syndrome 
throughout life [67]. Even the studies in pregnant women is scare due to ethical reasons. To the best of our 
knowledge, there are no works studying the influence of MD adhesion in maternal-fetal microbial transfer. 
One the other hand, in vivo studies with high-fat diet during pregnancy (contrarily to what is encouraged in 
the MD) showed that female mice fed with a high-fat diet before and during pregnancy led to an increased 
risk of offspring obesity [68]. The impaired gut barrier integrity, increased circulation levels of LPS, increased 
placenta hypoxia and impaired placenta vascularization found in the high-fat group may be the reason of this 
association [68]. 
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 Mode of delivery 
Regardless of when the first microbial colonization occurs, it is known that is during delivery that takes place 
the greatest microbial colonization of the newborn. While infants born by vaginal delivered receive a 
microbiota similar to the maternal vagina (through the passage on cervix and vagina), C-section delivered 
infants are enriched in skin microbiota, hospital staff and environment [69] (Figure 3). Infants born by vaginal 
delivery showed more Lactobacillus and Prevotella [70]. On the other hand, C-section delivered infants were 
associated with lower biodiversity, a delay in colonization by beneficial bacteria and higher colonized by 
Staphylococcus, but less colonized by Enterococcus [71]. 
Despite some contradictory works, it is assumed that the mode of delivery may play a decisive role in the 
development and growth of the newborns, since the bacteria present in fetal gastrointestinal tract can 
influence the development the immune system and therefore have relevant health consequences [72]. As 
mentioned by Dominguez-Bello, “Epidemiological studies, although not showing causality, have reported 
associations between C-section delivery and an increased risk of obesity, asthma, allergies and immune 
deficiencies” [73]. So, to minimalize the disruption of vertical transmission of microbiota provoked by C-
section, it was developed a technique to “restore” the microbiota of these infants. A sterile gauze was pass 
first in the mother’s vagina after the surgery and, immediately after, the same gauze was applied in the 
newborn (mouth, face and in rest of the body) [73]. Despite these procedure restored the infant’s gut, oral 
and skin microbiota, it is important to ensure the costs and potential risks [74]. More recently, it was reported 
that the mode of delivery had a temporary and little effect on infants gut microbiota and the  gestational age 
seems to be the main driver [75]. 
 
The preterm infant’s microbiota 
A healthy full-term vaginal delivered and exclusively breast-fed infant has been considered to be the standard 
for a healthy infant microbiota [76]. On the other hand, preterm infants born by C-section, fed with formula 
and exposed to antibiotics have abnormal patterns of colonization with lower abundance of “healthy” bacteria 
as Lactobacillus and Bifidobacterium [58]. Despite the very high variability between preterm infants [77], their 
microbiota composition is significantly different from that of the full-term infants [78]. Table 2 summarizes the 
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Table 2 - Principal bacteria groups in preterm infants. Adapted from Underwood et al, 2017 [79]. 


































































- ,Gram-negative bacteria; +, Gram-positive bacteria; ▫, facultative anaerobic; •, strict anaerobic 
 
Preterm infants – defined as an infant born before 37 weeks of pregnancy, that includes very preterm infant 
born between 28 and 32 weeks and extremely preterm born before 28 weeks [80] – born to soon due to 
different reasons. Cervical and vascular disorders, uterine overdistension, breakdown of maternal-fetal 
tolerance and environmental factors as maternal age at pregnancy, maternal chronic diseases, maternal 
nutritional status and infection are some of the factors that can lead to premature labor [80,81]. 
The preterm infant presents an immature intestinal microbiota with a marked vulnerability to dysbiosis, with 
a change in abundance, diversity and progressive acquisition of bacteria. If, on the one hand, premature infants 
present an immature gut, immune system and metabolism, they also require long hospitalization leading to a 
colonization mainly by bacteria from the neonatal intensive care unit (NICU) and invasive procedures as 
intravenous access, parenteral feeding and mechanical ventilation [82]. Premature infants are exposed to 
endogenous factors, environmental and maternal and postnatal therapeutic conditions that constitute an 
imminent trigger for infection and, consequently, dysbiosis (Figure 5). 
An inflammatory status in preterm infants – which can be triggered even in utero – can affect all organs (Figure 
5). Late-onset sepsis and necrotizing enterocolitis (NEC), a very common cause of morbidity and mortality in 
preterm infants, were associated with microbiomes dominated by Proteobacteria and Firmicutes [71] – the 
dominant phyla of the preterm infant microbiota [77]. As reviewed by Staude et al (2018), an imbalanced gut 
microbiota in preterm infants, could contribute to impaired somatic growth and psychomotor development, 
bronchopulmonary dysplasia, retinopathy of prematurity, cardiovascular diseases and behavioral and stress 
responses (Figure 5) [83]. 
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Figure 5 - Gut microbiota of preterm infants. Environmental and endogenous factors, as well as pre- and postnatal therapeutic 
interventions can determine the composition of gut microbiota of preterm infants. The impact of gut microbiota in NEC, 
nosocomial infection, psychomotor development, hormonal balance, autonomic nervous system and somatic growth have been 
reported. On the other hand, the association of gut microbiota and others short and long term-morbidities is unclear. Adapted 
from Staude et al, 2018 [85]. 
To combat this high susceptibility to infection and pathological bacteria in preterm infants, antibiotherapy is 
used, in most of the cases, either ante- and postpartum. However, data show that concerns should be taken 
when administering antibiotics due life threatening morbidities [58]. One study with 4039 preterm infants 
from 19 neonatal centers, showed that empirical and prolonged antibiotic therapy (≥ 5 days) was associated 
with increased odds of death and NEC [84]. In line with these, another study found that administration of 
antibiotics for 5-7 days on the first postnatal week lead to more cases of NEC, sepsis and death [85]. These 
preterm infants presented lower bacterial diversity and an increased abundance of Enterobacter [85]. One 
study that gathered 10 premature infants, found that only one single infant was dominated by Bifidobacterium, 
since it was also the only baby that did not receive antibiotic treatment during the first four weeks of life [77]. 
Perinatal antibiotic exposure also affected “strongly” the initial microbiota establishment in the preterm 
infants [76]. In addition, a recent study that analyzed 436 mother-child pairs followed until 7 years of age, 
found that children born from mothers who were given antibiotics during the second or third trimester of 
pregnancy had an 84% higher risk of obesity at age 7, but the use of antibiotics in the first trimester had no 
effect [86]. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 
25 
Microbiota in early life is crucial to a healthy maturation of the immune system and other organs [83]. It is 
essential to identify strategies to establish a healthy early microbiota in preterm infants, since it provides 
antigenic stimulus for the adequate development and maturation of the immune system, intestine and even 
distal organs [69]. For instance, providing breast milk to preterm infants during hospitalization led them to 
developed a normal microbiota resembling that of term infants [87]. 
 
The impact of the infant feeding 
In premature infants, especially in very and extremely preterm infants, an appropriated nutrition is essential 
to decrease the risk of adverse health outcomes and to improve cognition in adulthood [88]. According to 
international guidelines [88,89], which are contemplated in national recommendations [90], mothers’ own 
milk (MOM) is always the first choice to fed preterm infants. However, MOM is not always available and 
sometimes it is insufficient. In that cases pasteurized donor human milk (DHM) should be administrated [91]. 
When Human Milk (HM – that comprises MOM and DHM) is unavailable, bovine-based preterm formulas 
(designed as formula hereinafter) should be used. 
Breast milk composition changes through the course of gestation and lactation, and even with the time of the 
day [89]. Despite the protein, fat and carbohydrates source, HM is a “carrier of biochemical messages” that 
modulate the growth, development and the immune system of the newborn [92]. The composition of the 
breast milk of mothers that delivered preterm infants is significantly different that mothers that delivered at 
term, namely in protein and fat contents that are higher in preterm breast milk (Table 3) [93]. The most 
abundant proteins present in the HM are casein, α-lactalbumin, lactoferrin, secretory immunoglobulin IgA, 
lysozyme, serum albumin and antimicrobial peptides [92,93]. HM also contains other bioactive compounds 
such as essential fatty acids, enzymes, growth factors and hormones that have immune-related functions 
[89,92,93]. The main source of carbohydrates in HM is lactose and is the least variable macronutrients [93]. 
HM also contained oligosaccharides – HMOs – that are glycosylated compounds synthesized in mammary 
gland by glycosyltransferases. HMOs are remarkable components of breast milk due to their prebiotic effect 
stimulating the growth of beneficial bacteria [93]. 
Furthermore, breast milk is a source of probiotics providing commensal bacteria to the infant. The literature 
suggests that breast milk still contains 106 bacteria cells per mL, with a dominance of Staphylococcus, 
Streptococcus (both bellowing to Firmicutes phylum) and Pseudomonas (Proteobacteria phylum) [94]. Two 
potential mechanisms can explain the presence of bacteria in breast milk. In a nutshell, mothers’ skin 
microbiota and infants’ oral can reach breastmilk through retrograde flux [95]. In addition, it has been 
demonstrated that dendritic cells (and macrophages) can pass intestinal epithelium through the expression of 
tight-junctions proteins to take up commensal bacteria and, via lymph/blood circulation, reach the mammary 
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gland [96]. This process showed to occur during late pregnancy and lactation in mice [97]. This may be the 
reason why in premature MOM the percentage of bacteria present in milk samples was lower [98]. Despite 
the lower total bacterial content in preterm breast milk (n = 19) compared to term breast milk (n = 13), no 
significantly difference were observed (Table 3) [99]. Staphylococcus, Streptococcus, Lactobacillus, 
Enterococcus and Enterobacteria were the main genera isolated in milk from preterm gestations with 
Bifidobacterium concentration significantly decreased compared to term milk [98,99]. 
Table 3 - Energy, macronutrient and total bacterial content composition of breast milk from mothers who delivered term 
and preterm; DHM and preterm infants formula [93]. 
 MOM term MOM preterm DHM Formulaa 
Energy (kcal/dL) 65 – 70 78 50 – 115 80 
Protein (g/dL) 0.9 – 1.2 2.2 0.6 – 1.4 2.6 
Fat (g/dL) 3.2 – 3.6 4.4 1.8 – 8.9 3.9 
Lactose (g/dL) 6.7 – 7.8 7.6 6.4 - 7.6 5.6 
HMO (g/dL) 0.817 [100] 0.857 [100] 0.8 [101] 0.8b 
Bacterial content  5.37 Log (gene copies ml–1) [99] 5.00 Log (gene copies ml–1) [99] 102 CFU/mL [102] n.a. 
a The composition of the formula described above refers to the commercial formula Aptamil Prematil, Milupa Danone®, 
which was used in the preterm infants included in this study; b The total amount oligosaccharides present in formulas 
is the sum of GOS (0.72 g/dL) and FOS (0.08 g/dL); n.a. – information not available. 
 
MOM composition is also influenced by protein intake, parity, return of menstruation and nursing frequency 
[93]. Maternal diet also influence breast milk composition. A very recent study demonstrated the adherence 
to MD lead to a 10-fold higher Lactobacillus abundance in mammary glands of female monkeys compared to 
the Western diet group [7]. Likewise, maternal body mass index (BMI) showed to have influence: breast milk 
from obese mothers (n = 10) had more bacterial content, but it was less diverse when compared to normal 
weight mothers (n = 8). More, these mothers had lower content of Lactobacillus in colostrum and 
Bifidobacterium at 6 months [103]. 
Despite the rapidly increase of human milk banks, DHM is not available to all preterm infants. In Portugal, for 
example, there is only one human milk bank. Typically, DHM is provided by mothers who delivered at term 
that have excess milk production. Thus, DHM is a term and late lactation milk and require additional protein 
and fat acids supplementation. Moreover, DHM is submitted to Holder pasteurization (62.5°C for 30 minutes) 
to avoid transmission of infectious agents. Due to these reasons and to the handling and storage procedures, 
the DHM presents some differences in their composition in relation to preterm MOM (Table 3) [104,105]. 
Some compounds, such as protein, lactose, long-chain polyunsaturated fatty acids, vitamins (A, D, E, B12, B9) 
and some growth factors are preserved [91]. On the other hand, bioactive compounds of breastmilk are 
affected. B and T lymphocytes, macrophages, neutrophils, as well as lipoprotein lipase and IgM are inactivated. 
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The lactoferrin concentration decreased 50-75%, as well 24-74% of lysozyme and 20-30% of IgA [91]. 
Pasteurization procedure does not decreases the HMOs content (Table 3) [106]. However, the content of 
HMOs in DHM presented significantly lower amount of total HMOs in comparison to MOM [101]. The heat 
treatment leads to the inactivation of viruses and kills 99% of bacteria. However, Cacho et al. (2017) found 102 
CFU/mL of bacteria in 44% of DHM [102]. The most abundant genera identified were Acinetobacter, 
Enterobacteriaceae and Serratia (all bellowing to Proteobacteria phylum). These authors used a small amount 
of MOM to inoculate the pasteurized DHM, making possible to personalize DHM with MOM microbiota [102]. 
This could be a promising and innovative method to provide beneficial bacteria to preterm infants. 
Contrarily to HM, formulas have a very standardized composition (Table 3). Preterm formulas contain all 
essential nutrients to provide a good growth and development to infants [88]. Although formula offers a similar 
percentage of total calories from fat in relation to MOM, the composition of specific fatty acids can be very 
different, as well the bioactive compounds [107]. Synthetic HMOs (namely, galatooligosaccharides – GOS and 
fructooligosaccharides - FOS) are added to formula. However, these molecules are structurally different from 
that naturally present in HM [108]. These differences could influence the immunogenic development of 
preterm infants [108]. Regarding the bacterial content, during preparation, powdered formulas may be 
contaminated [109]. In NICU, single doses of sterile liquid infant formula should be used [109]. 
It is possible to understand why the type of infant-feeding influence in different ways the development of the 
preterm infants’ health outcomes and their gut microbiota. There are several studies showing short and long 
term benefits associated with HM intake in preterm infants: lower incidence of NEC, late-onset sepsis and 
retinopathy of prematurity; better neurological development promoting a significantly intelligence quotient in 
later years; lower risk of hypertension and atherosclerosis in adulthood [88]. Moreover, in preterm infants the 
intake of both MOM and DHM were associated with better feeding tolerance, shorter duration of hospital stay 
and reduced hospital costs [110]. 
Due to prebiotic and probiotic properties, preterm infants fed with MOM showed a greater initial diversity of 
gut microbiota compared infants fed non-MOM [111,112]. An effect that was maintained until 30 postnatal 
days [112]. On the other hand, in DHM and formula-fed infants the rate of diversity was slow over in time and 
at 30 postnatal days the diversity index was lower [113]. A recent study did not found differences in microbial 
diversity and richness between the feeding types [114]. However, significantly differences were found in 
bacterial profile [114]. Despite Bifidobacteriales showed to be higher in infants fed with MOM compared to 
DHM and formula infants [115], DHM showed closer microbial profiles to MOM than formulas [114]. 
Microbiota profile of breast-fed infant’s changes to a formula-fed infant profile, with significant increase in the 
count of Enterococci and Enterobacteriaceae, and the appearance of Bacteroides and Clostridium [115]. 
Although, no significant differences were observed between MOM and formula-fed preterm infants at fourth 
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week of life [115]. MOM was reported to mitigate the effect of gestational age (gut immaturity) [111]. In fact, 
preterm infants fed with HM could develop a microbiota similar to the term infants, independently of being 
MOM or DHM [75]. 
The available data support that maternal microbiota as well as newborns postnatal microbiota contribute to a 
healthy or disease status of preterm infants with short- and long-term consequences. Exposure to a diversity 
of commensal species regulate local microbial growth, modulate the morphology and function of enterocytes, 
reduce activation of proinflammatory cascade and affect gene expression [116]. 
  




The goal of this observational study was to evaluate the impact of different types of infant feeding (MOM, 
DHM and formula) on the gut microbiota of preterm infants hospitalized in NICU of Maternidade Alfredo da 
Costa (MAC). Furthermore, the influence of mode of delivery and mother’s diet on vertical microbiota 
transmission were also evaluated. 
 
Specifically, the aims of this study were: 
- to characterize the preterm gut microbiota;  
- to characterize the maternal gut microbiota;  
- to evaluate the impact of maternal gut microbiota, antepartum factors (dietary pattern, pre-gestational 
body mass index, antibiotic therapy) and perinatal factors (gestational age and mode of delivery) on the 
bacterial colonization of preterm infants;  
- to evaluated the influence of the infant feeding on preterm gut microbiota during the first 26 days of life.   




This study protocol was approved by the Ethics Committee of Centro Hospitalar Universitário de Lisboa Central 
(Ref. 443/2017) and by the Ethics Committee of NOVA Medical School|Faculdade de Ciências Médicas, 
Universidade NOVA de Lisboa (NMS|FCM). The study was conducted in accordance to the ethical principles 
expressed in the Declaration of Helsinki, the Portuguese law and Good Clinical Practice guidelines. 
 
Study Design 
The FEEDMI Study was an observational longitudinal study, conducted at the NICU of MAC and NMS|FCM. 
The study is registered in ClinicalTrials.gov platform, with the registration number NCT03663556. The detailed 






Figure 6 - Study timeline. After obtaining informed consent from legal representatives, infants will be enrolled in the study. The 
first stool sample will be collected within the first 24 hours after birth, followed by three subsequent collections every 7 days. 
 
Participants Recruitment 
Very preterm infants (< 32 weeks gestational age) hospitalized in the NICU of MAC were recruited within the 
first 24 hours after birth. Inclusion criteria are displayed in Figure 6. Written informed consents were obtained 
for each preterm infant after explaining the entire study protocol to their legal representatives. 
 
Sample Collection 
Meconium, the newborn’s first intestinal discharge, and the 3 additional fecal samples of preterm infants were 
collected by the nursing team of MAC’s Neonatology Unit. Fecal samples were collected weekly from diapers 
into sterile tubes. Mothers were also asked to collect their own fecal samples with an appropriate stool 
collection kit (EasySampler®). 
Inclusion criteria 
- Admission at NICU in less than 24 hours 
- Gestational age < 32 weeks 
- Absence of congenital malformations or        
metabolic diseases 
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Clinical Data Collection 
Detailed clinical data were collected during the preterm infant enrollment in the study through medical 
records. Personal clinical data include sociodemographic information and clinical intrapartum and postpartum 
outcomes such as newborn’s somatometry evolution, antibiotic exposure and its duration, number of total 
days of hospitalization, and other outcomes related to the preterm clinical evolution. Additionally, type of 
infant-feeding (MOM, DHM and formula) was recorded daily to select the most representative (> 50 %) type 
of infant-feeding received during the 7 days prior to each fecal sample collection. 
 
Microbiota Analysis 
Fecal sample collection is a non-invasive procedure commonly used to assess the intestinal microbiota 
composition. Bearing in mind meconium’s tar-like texture and samples’ low bacterial amount [118], DNA were 
extracted and purified from stool samples using NZY Tissue gDNA Isolation Kit (nzytech, Lisbon, Portugal), as 
previously described [119]. 
Different bacterial populations were analyzed by quantitative real-time PCR using LightCycler instrument 
(Roche Applied Science, Indianapolis, ID, USA). Specific microorganisms were assessed based on previous 
studies regarding preterm gut microbiota composition [111,120–122]. Two phyla (Bacteroidetes and 
Firmicutes), one class (γ-Proteobacteria), four genera (Lactobacillus, Bifidobacterium, Bacteroides and 
Enterococcus) and one specie (Escherichia coli) were analyzed of preterm infants’ samples. In mothers’ 
samples, the same bacteria groups were analyzed in addition to Prevotella and Akkermansia. Primer sequences 
used to target bacterial 16S rRNA genes were described in Table 4. Results on microbiota are expressed as 
log10 16S rDNA gene copies/10ng of DNA.  
 
Quality Control Analysis 
Increasing evidence has been suggested that DNA extraction kits and other laboratory reagents are commonly 
contaminated [123]. This contamination could have a critical impact on results, especially in samples 
containing low microbial biomass [123], such as preterm infants. For control purposes, a fecal collection was 
simulated: an empty tube (that same tubes used for collecting meconium and feces samples) was opened 
inside the infants’ incubator and the spatula was passed through diaper; the tube was stored under the same 
conditions as the others; in the lab, it was added 200 mL of ultrapure water into the tube; and DNA was 
extracted. In addition, DNA amplification was performed in duplicated and samples with lower levels than 
negative controls (from extraction and PCR procedures) were discarded.  
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Table 4 - Primers sequences used for gut microbiota analysis. AT, annealing temperature. 
Target group Primer sequence (5’-3’) Genomic DNA Standard AT Ref. 
Total bacteria 
AAA CTC AAA KGA ATT GAC GG 





CAT GTG GTT TAA TTC GAT GAT 





ATG TGG TTT AAT TCG AAG CA 
AGC TGA CGA CAA CCA TGC AC 










GAG GCA GCA GTA GGG AAT CTT C  
    GGC CAG TTA CTA CCT CTA TCC TTC TTC 




CGC GTC YGG TGT GAA AG  





ATA GCC TTT CGA AAG RAA GAT 





CCC TTA TTG TTA GTT GCC ATC ATT  
         ACT CGT TGT ACT TCC CT TGT 
Enterococcus gilvus 















GTA AGT TAC ACT ATA AAA GCA CCG TCG 





Maternal Mediterranean Diet Adherence Score 
Mothers were requested to completed a semi-quantitative Food Frequency Questionnaire (FFQ), previously 
validated for the Portuguese population [128,129]. In the current study, the FFQ with 86 items was used to 
assess food consumption during pregnancy. Response options are in a 9-point frequency scale, ranging from 
‘never’ to ‘≥ 6 times per day’. Using portion sizes and frequency of consumption, daily portions (g/day) were 
computed for each FFQ item. Data from FFQ was used to calculate the MD adherence score using 13 items of 
the original questionnaire [130]. The following items were classified with 1 point if the answer to the question 
was “YES”: olive oil as main culinary added fat/oil; olive oil ≥ 4 daily tablespoons; vegetables (including 
vegetable soup) ≥ 2 daily serving; fruit ≥ 3 daily servings; legumes ≥ 3 weekly servings; fish/seafood ≥ 3 weekly 
servings; tree nuts ≥ 1 weekly serving; and more poultry than red meat. If the answer was “NO”, the item was 
classified with 0 points. On the other hand, the following items were classified with 1 point if the answer to 
the question was “NO”: red/processed meat ≥ 1 daily serving; butter, cream and margarine ≥ 1 daily serving; 
sugar-sweetened beverages ≥ 1 daily serving; sweets and confectionary ≥ 3 weekly servings; and any 
consumption of wine. If the answer was “YES”, the item was classified with 0 points. The MD adherence score 
ranged, therefore, from 0 to 13 points, where higher scores (≥ 10 points) reflect better adherence to the MD. 
Table 5 summarizes the portion sizes used in each item. 
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Table 5 - Description of the food groups and respective portion sizes used to assess the MD adherence score. 
Food Group Description Cut-off 
Olive oil Olive oil ≥ 4 servings/day (1 serving = 10 g) 
Vegetables All raw and cooked vegetables ≥ 2 servings/day (1 serving = 180 g) 
Fruits All fruits and 100% fruit juices ≥ 3 servings/day (1 serving = 160 g) 
Legumes Bean, chickpeas, lentils, peas ≥ 3 servings/week (1 serving = 150 g) 
Nuts Nuts, almonds, pistachios, walnuts, cashews ≥ 1 servings/week (1 serving = 30 g) 
Fish/seafood 
Fresh-water and sea-water fish, preserved fish 
(tuna, sardines), selfish (squid, prawns) 
≥ 3 servings/week (1 serving = 150 g) 
Red/processed meat Beef, pork, lamb, goat, sausage, ham, bacon ≥ 1 servings/day (1 serving = 125 g) 
Fats and oils Butter, cream and margarine ≥ 1 servings/day (1 serving = 12 g) 
Sugar-sweetened 
beverages 
Soft drinks, fruit juices or packages nectars ≥ 1 servings/day (1 serving = 330 ml) 
Sweets 
Cookies, croissants, doughnut, homemade cakes, 
chocolate (tablet or powder). Chocolate snacks. 
≥ 3 servings/week (1 serving = 80 g) 
 
Statistical Analysis 
Statistical analysis was performed by SPSS software, version 25 (IBM SPSS Statistics corporation, Chicago, IL, 
USA). The normality of the data, at each sampling point, was checked using the Kolmogorov-Smirnov test. 
Comparisons between groups were performed using t-test, Mann-Whitney test or Fisher’s exact test, as 
appropriated depending on value distribution. In order to evaluate the impact of different BMI categories and 
types of feeding on the evolution of gut microbiota composition, a non-parametric test (Kruskal-Wallis) was 
used. Univariate and multivariate linear regression analysis adjusted for gestational age, mode of delivery, 
gestational diabetes and antepartum antibiotic therapy were performed to investigate the association 
between mean Mediterranean Score (independent) and the microbes’ abundance in meconium samples 
(dependent variables). In addition, multivariate linear regression analysis adjusted for gestational age, infants’ 
antibiotherapy and mean Mediterranean Score were fitted to study the association between infant feeding 
(independent) and the microbiota composition of preterm infants at 26th postnatal day (dependent variables).  
Data are expressed as mean ± standard deviation (SD). The differences were considered statistically significant 
when p < 0.05.  




Clinical characterization of the preterm infants and their mothers 
A total of 159 preterm infants were recruited consecutively from the NICU between May 2017 and April 2019. 
Forty-two were excluded: 14 for not meeting the inclusion criteria, 13 due to early death, 7 for having 
nonconformities in their fecal samples, 4 for early discharge, 3 were transferred to another hospital, and 1 for 
unknown perinatal factors. The remaining 117 preterm infants include 22 pairs of twins and one set of triples. 
The respective mothers of the eligible preterm infants (n = 93) were also enrolled in this study (Figure 7). 
Figure 7 - Flowchart identifying study population 
Preterm infants were born at gestational age between 25 and 31 weeks with birthweights ranging from 455 
to 2020 g. The majority of the infants were male (56%) and delivered by cesarean-section (C-section). Clinical 
data of preterm infants is reported in Table 6. 
Enteral feeding was introduced between the first and sixth postnatal day and the exclusive enteral feeding 
was achieved at 15 ± 8 postnatal days. Preterm infants were fed with their MOM, DHM and/or infant formula. 
Considering the most predominant type of infant feeding the one that represented more than 50% of the total 
feedings during the study period, 64.7% of the infants were fed with MOM. Twenty infants were fed 
predominantly with DHM and 13 with infant formula. In some cases, infants received mixed feeding of MOM 
plus DHM (design as HM, n = 6) or MOM plus formula (n = 1). Due to specific clinical conditions, a preterm 
infant was fed mainly by parenteral feeding, reaching exclusive enteral feeding at 48 postnatal day.  
Preterm Recruited 
n = 159 
Preterm infants assessed for eligibility 
n = 117 
Excluded 
n = 42 
Preterm infants’ mothers 
n = 93 
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Eight infants had culture positive early onset infection and 46 had late-onset sepsis. Two of them were 
diagnosed with NEC at 34 and 36 days of life. The infants received a mean of 11 days of antibiotics. Six infants 











The mean age of preterm infants’ mothers was 34 years of age. The majority of mothers had normal weight 
before pregnancy. The mean gestational weight gain at the end of the pregnancy was 8.7 kg. Overall, 12 
mothers had gestational diabetes and 50 received antepartum antibiotic therapy. Of the 59 mothers that 
completed the FFQ, only 9% (n = 15) showed adherence (MD score > 10) to MD during pregnancy. Mothers’ 








Table 6 - Clinical characteristics of preterm infants. 







Gestational age, weeks  (mean ± SD) 28.6 ± 1.9 
Extremely premature/very premature, n 34/83 






Somatometry at birth (mean ± SD) 
Weight, g 
Length, cm 
Cephalic perimeter, cm 
 
1177 ± 419 
36.8 ± 3.3 
25.7 ± 2.3 








Days of antibiotherapy (mean ± SD) 12 ± 10 
Days of hospitalization (mean ± SD) 56 ± 10 
Table 7 - Preterm infants’ mothers’ characteristics. 
Mothers, n = 93 
Age, years (mean ± SD) 34 ± 6 










Gestational weight gain, kg (mean ± SD) 8.7 ± 5.3 
Gestational Diabetes, n 12 
Maternal Antibiotherapy, n   50 
Mediterranean Diet Adherence, n (yes/no) 15/44 
Rupture of membranes, n 
Intrapartum  
< 18 hours 







                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 
36 
Characterization of the preterm infants’ and mothers’ microbiota 
In total, 389 fecal samples from preterm infants were obtained at an average postnatal age of 2 (corresponding 
to meconium samples), 10, 18 and 26 days. From a total of 100 meconium samples collected, only 66 were 
collected before 72 hours of life. Of the 66 meconium samples, bacterial DNA were not detected in 8 samples, 
as well as no DNA was detected in the negative control collected from a preterm infant’s diaper. Meconium 
samples collected over 72 hours were discarded due to their greater amount of total bacteria (p = 0.003), 
reflecting an additional bacterial colonization due to external factors (NICU environment and medical and 
nursing contact). 
In general, bacterial levels increased during the 26 days of life (Figure 8). The intestine of preterm infants 
showed a significant bacterial colonization after the second day of life (p < 0.001) (Figure 8a). Proteobacteria 
was the most abundant phylum in all time-points and, along with Firmicutes, increased over time (p < 0.001). 
On the other hand, Bacteroidetes phylum abundance decreased between the 2nd and 10th day of life (p < 0.001) 
and remained unaltered until day 26 (Figure 8b). 
Of the all genera analyzed, in meconium samples Bifidobacterium was the most abundant genus (Figure 8c). 
At the 10th postnatal day, Bacteroides assumed this position. However, the Enterococcus content increased 
over time and was the most prevalent genus in fecal samples at 18th and 26th day of life (p < 0.001) (Figure 8c). 
The abundance of Lactobacillus and Bifidobacterium was the same over the time (p = 0.201 and p = 0.176, 
respectively). Interestingly, in extremely premature newborns’ meconium (born before 28 gestational weeks) 
the amount of Lactobacillus is higher than in very preterm infants (1.442 ± 0.822 vs. 1.036 ± 1.052, p = 0.024), 
regardless of the mode of delivery. However, between the 2nd and 10th day, extremely preterm infants had a 
decreased in Lactobacillus (p = 0.008) maintaining the same amount as very preterm infants until the 26th day. 
Gestational age did not influenced any other differences in infants’ microbiota. 
Bacteroides were only identified in 65% of the meconium samples and in 45-60% of the remaining fecal 
samples. In preterm infants colonized with Bacteroides, results were not different between the four time 
points (p = 0.145) (Figure 8c). The abundance of E. coli, the only species analyzed in this study, increased 
significantly over time (p < 0.001) (Figure 8c). Infants born by C-section presented a greater amount of E. coli 
in meconium compared to vaginal delivery infants (2.497 ± 1.302 vs. 1.848 ± 0.784, p = 0.042). In addition, 
these infants had a lower amount of Bacteroides at the 10th postnatal day (6.973 ± 2.010 vs. 2.799 ± 0.199, p 
= 0.024]. Besides these differences, the mode of delivery did not show other influences on infants’ microbiota. 
From mothers, 64 postpartum fecal samples were analyzed. Comparing to their mothers’, gut microbiota of 
preterm infants showed a lower amount of total bacteria during the first 26th days of life (p < 0.001) (Figure 
8d). The most abundant phylum in mothers’ fecal samples was Firmicutes (Figure 8e). With the exception of 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 
37 
meconium samples, preterm infants presented an increased amount of γ-Proteobacteria compared to their 
mothers (p < 0.001). Interestingly, after birth, preterm infants’ meconium had the same amount of 
Lactobacillus as their mothers (p = 0.146) and the content of Bifidobacterium was also the highest in both 
mothers and infants (Figure 8f).  
 
Figure 8 - Specific bacterial levels groups in meconium and fecal sample of preterm infants (a, b, c) and in their mothers fecal 
samples (d, f, e). * Differences in relation to meconium; # differences between mothers’ samples and infants’ samples at 10th, 
18th and 26th days. 
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Considering antepartum factors, such as pre-gestational BMI, gestational weight gain and adherence to MD, 
no differences were observed on mothers’ fecal microbiota. However, gestational diabetes promoted a lower 
amount of E. coli (p = 0.020). 
Fetal membrane rupture over 18 hours before delivery showed to be a major determinant of postpartum 
maternal microbiota. Women who had their membranes ruptured for over 18 hours presented a lower 
content of total bacteria, Bacteroidetes, γ-Proteobacteria, Bifidobacterium, Prevotella and E. coli compared to 
those whose fetal membranes ruptured intrapartum (Table 8). Membranes ruptured for less than 18 hours 








The lower amount of specific bacteria found in mothers with membranes ruptured for more than 18 hours 






In agreement, antepartum antibiotic exposure had a major impact on mothers’ microbiota. Compared to 
mothers who did not take antibiotics before giving birth, those exposed to antibiotic therapy had less bacterial 
content and lower abundance of Firmicutes, Lactobacillus, Bifidobacterium, Akkermansia and Prevotella (Table 
10). 
Table 8 - Influence of fetal membranes ruptured intrapartum on the mothers’ microbiota (mean ± SD). 
 Intrapartum < 18 hours > 18 hours p-value a 
Total Bacteria 6.064 ± 0.545 5.947 ± 0.501 5.693 ± 0.489 0.008 
Bacteroidetes 5.225 ± 0.760 4.659 ± 1.155 4.701 ± 0.696 0.030 
Firmicutes 5.818 ± 0.633 6.094 ± 0.563 5.518 ± 0.511 0.116 
γ-Proteobacteria 5.200 ± 0.760 4.810 ± 0.610 4.650 ± 0.740 0.034 
Lactobacillus 1.909 ± 0.967 1.540 ± 0.997 1.757 ± 1.152 0.326 
Bifidobacterium 5.963 ± 0.970 5.065 ± 1.526 3.646 ± 1.077 0.001 
Bacteroides 4.963 ± 1.313 4.709 ± 1.699 4.405 ± 1.287 0.099 
Enterococcus 3.080 ± 0.677 3.207 ± 0.746 3.062 ± 0.583 0.934 
Prevotella 3.128 ± 0.957 2.660 ± 0.752 2.304 ± 1.004 0.007 
Akkermansia 2.200 ± 1.551 2.804 ± 1.353 2.238 ± 1.313 0.093 
E. coli 4.427 ± 1.156 4.377 ± 0.853 3.212 ± 0.957 0.001 
a p-value between intrapartum rupture membranes and membranes ruptured for over 18 hours 
Table 9 - Fetal membranes rupture and antepartum antibiotic exposure. 
 n   
 No-antibiotic exposure Antibiotic exposure p-value 
Rupture of membranes 
Intrapartum 
< 18 hours 














In order to verify whether antibiotic use mitigated the effects of pre-gestational BMI, gestational weight gain, 
adherence to MD and gestational diabetes on the maternal microbiota, only mothers who were not exposed 
to the antepartum antibiotics were considered for analysis and no differences were found. 
 
Establishment of the meconium microbiota of preterm infants 
Mother-to-infant bacterial transmission 
Altogether, 35 mother-infant pairs had fecal and meconium samples collected, respectively. The total bacteria 
content of infants did not correlated with mothers’ microbiota. However, Firmicutes of the mothers’ samples 
correlated positively and strongly with that of the infants (Figure 9c). This correlation was maintained until the 
10th day of life, despite losing strength [ρ = 0.408 (p = 0.012)]. The γ-Proteobacteria content also showed a 
positive correlation between mothers’ and infants’ microbiota (Figure 9d). On the other hand, Bifidobacterium 
correlates negatively, but weakly, between mothers and preterm infants (Figure 9f). 
Regarding the mode of delivery, among 14 vaginal deliveries, no correlation was observed between mothers’ 
and infants’ microbiota. However, among 21 C-section deliveries, microbiota of mother-infant pairs were 
correlated. The Firmicutes and γ-Proteobacteria content between mothers’ feces and preterm infants’ 
meconium were positively correlated, showing higher correlation coefficients than in the vaginal group [0.657 
(p = 0.002) and ρ = 0.557 (p = 0.013), respectively]. Bacteroides was also positively and strongly correlated [ρ 
= 0.733 (p = 0.007)]. 
Table 10 - Influence of antepartum antibiotic exposure on the mothers’ microbiota (mean ± SD). 
 No-antibiotic exposure (n = 29) Antibiotic exposure (n = 34) p-value 
Total Bacteria 6.087 ± 0.593 5.857 ± 0.446 0.017 
Bacteroidetes 5.193 ± 0.679 4.807 ± 0.888 0.061 
Firmicutes 5.991 ± 0.649 5.686 ± 0.554 0.024 
γ-Proteobacteria 5.180 ± 0.790 4.900 ± 0.740 0.163 
Lactobacillus 2.018 ± 0.971 1.550 ± 0.967 0.035 
Bifidobacteria 5.957 ± 1.018 4.628 ± 1.492 0.001 
Bacteroides 5.130 ± 1.214 4.582 ± 1.425 0.055 
Enterococcus 3.017 ± 0.657 3.156 ± 0.789 0.455 
Prevotella 3.216 ± 0.981 2.597 ± 0.843 0.016 
Akkermansia 3.315 ± 1.656 2.518 ± 1.250 0.031 
E. coli 4.380 ± 1.091 4.113 ± 1.205 0.310 
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Figure 9 - Scatterplots showing the association between mother microbiota and their infants’ meconium (spearman correlation). 
X-axis represents the bacterial content of individual infant. Y-axis represent their mothers’ bacterial content. 
In order to determine the effect of gestational age on bacterial transfer from mother to offspring, the same 
analysis was performed for infants born before and after 28 weeks of gestation. Interestingly, no correlations 
were found in the microbes analyzed between the mothers’ feces and the extremely preterm infants’ 
meconium (n = 11). However, in preterm infants born during the third trimester (between 28 and 32 weeks 
gestation) the content of Firmicutes and Bacteroides correlated positively and strongly [ρ = 0.523 (p = 0.013) 
and ρ = 0.728 (p = 0.007), respectively]. 
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Rupture of membranes and maternal antepartum antibiotics exposure 
As observed in mothers, membrane rupture also influenced the preterm infants’ microbiota right after birth. 
Compared with intrapartum membrane ruptured, infants born with membrane ruptured less than 18 hours 
had decreased levels of Lactobacillus (p = 0.025) and increased levels of E.coli (p = 0.023) (Figure 10). 
Infants born with membrane ruptured over 18 hours, presented decreased amount of total bacteria and 
Firmicutes. However, in comparison to < 18 hours group, membranes ruptured for more than 18 hours led to 
an increase in Lactobacillus (Figure 10). These differences were not explained by antepartum antibiotherapy. 
It was only noted that the offspring exposed to antepartum antibiotics had lower Enterococcus content in their 
meconium (1.669 ± 0.519 vs. 2.109 ± 0.903, p = 0.029). 
Figure 10- Influence of fetal membrane rupture on premature meconium microbiota. *differences in relation to intrapartum 
membrane rupture; # differences between membrane rupture for less than 18h and over 18 hours. 
 
Maternal diet 
Maternal adherence to MD during pregnancy was not associated with the microbial composition of the 
meconium (Figure 11). However, the analysis was limited by the number of mothers adhering to the MD whose 
infant’s meconium sample was collected in the correct conditions (n = 8). 
Figure 11 - Influence of maternal MD adherence on premature meconium microbiota. Mothers with MD adherence, n = 8; 
mothers with no-MD adherence, n = 23. 
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Univariate (crude) linear regression models of maternal diet (independent variable) and infants’ microbiota 
(dependent variable) were fitted (table 11). In addition, models adjusted for gestational age and mode of 
delivery (model 1) as well as gestational diabetes and maternal antibiotherapy (model 2) were fitted (table 
11). Maternal adherence to MD was significantly and negatively associated with Enterococcus in infants’ 
meconium after adjusting to gestational diabetes and maternal antibiotherapy (table 11). Concerning the 
other bacteria analyzed, no significant associations were observed. 
 
Maternal pre-gestational BMI and weight gain during pregnancy 
Regarding the maternal pre-gestational BM, no differences were also found in meconium microbiota of infants 
delivered by women with normal weight or overweight (Figure 12). However, some differences were detected 
in meconium microbiota between infants born to obese and normal weight or overweight mothers. 
Preterm infants born to mothers with normal weight, overweight or obesity had the same amount of total 
bacterial in meconium (Figure 12a). However, obese mothers delivered infants with significantly higher 
amount of Firmicutes compared to normal weight (p = 0.036) and overweight mothers (p = 0.002) (Figure 12b). 
These infants had more γ-Proteobacteria and Bacteroides compared to infants of overweight mothers (p = 
0.026 and p = 0.048. respectively). Surprisingly, the Bifidobacterium content was also higher in infants born to 
obese mothers compared to mothers with normal weight before pregnancy (p = 0.044) (Figure 12c). On the 
other hand, the amount of Lactobacillus was significantly lower (Figure 12c).  
Table 11 - Association between Mediterranean Diet Score (independent variable) and meconium microbes 
(dependent variables).  
 Model 0 Model 1 Model 2 
 β p β p β p 
Total Bacteria 0.310 0.423 0.397 0.368 0.105 0.781 
Bacteroidetes 0.516 0.267 0.602 0.200 0.560 0.262 
Firmicutes 0.231 0.548 0.567 0.137 0.070 0.851 
γ-Proteobacteria 0.075 0.810 0.187 0.551 -0.059 0.853 
Lactobacillus 0.261 0.397 0.261 0.371 0.403 0.207 
Bifidobacterium -0.112 0.726 -0.069 0.832 -0.190 0.555 
Bacteroides 1.174 0.163 1.089 0.344 1.239 0.109 
Enterococcus -0.484 0.111 -0.467 0.136 -0.616 0.044 
Escherichia coli -0.189 0.677 -0.096 0.836 -0.295 0.556 
Model 0 is univariate analysis; Model 1 is adjusted for gestational age and mode of delivery; Model 2 is 
adjusted for gestational diabetes and antepartum antibiotherapy  
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Figure 12 - Influence of maternal pre-gestational body mass index on premature meconium microbiota. Normal weight mothers, 
n = 33; overweight mothers, n = 15; obese mothers, n = 6; *differences between normal weight and obese mothers; #differences 
between overweight and obese mothers. 
 
The weight gain during pregnancy did not affect the preterm meconium microbiota. 
 
Gestational Diabetes 
Preterm infants whose mothers had GD also had lower Lactobacillus content in their meconium sample (1.256 
± 1.060 vs. 0.717 ± 0.615, p = 0.019). To understand if GD and obese mothers were the same, crosstab and 
chi-square analyses was performed (Table 10). Despite the low number of obese mothers, it was observed 
that the incidence of gestational diabetes differs according to the maternal pre-gestational BMI (p = 0.007) 
(Table 12). Specially, among normal weight and obese mothers (p = 0.009). 






Table 12 - Gestational diabetes by maternal pre-gestational BMI. 
 n 
 All Normal weight Overweight Obese p-value 
Gestational diabetes     0.007 
No 73 53 16 4  
Yes 12 5 3 4  
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Establishment of the intestinal microbiota of preterm infants until 26th of life 
Infant feeding 
Extremely preterm infants, those with less birth weight, length and cephalic perimeter, were preferably fed 
with MOM and DHM than formula (Table 13). During the study period, infants fed predominantly (more than 
50% of the total feedings) with formula showed a greater weight gain, lower days of antibiotherapy and total 
days of hospitalization (Table 13) compared to MOM and DHM. 
 
Significant differences were found in preterm infants’ microbiota regarding the feeding types during the study 
period (Figure 13). 
Figure 13 - Influence of feeding types on preterm infants’ microbiota during the first 26 days of life. *differences in relation to 
MOM; # differences in relation to DHM. 
MOM promoted a higher amount of Bifidobacterium than formula (p = 0.004). However, between MOM and 
DHM no differences were detected in Bifidobacterium content (p = 0.093). The same tendency was observed 
for Lactobacillus genus (Figure 13c). Preterm infants fed predominantly with MOM had higher levels of 
Bacteroides when compared to DHM group (p = 0.032) and to formula group (p = 0.013) (Figure 13c). DHM 
promoted a lower amount of Enterococcus when compared to MOM (p = 0.023) and formula (p = 0.029). 





(n = 20) 
Formula  
(n = 13) 
p-value 
(DHM vs MOM) 
p-value 
(Formula vs MOM) 
p-value 
(Formula  vs DHM) 
Extremely / very premature, n 28/47 5/15 0/13 0.205 0.004 0.065 
Somatometry at birth (mean ± SD) 
Weight, g 
Length, cm 
Cephalic perimeter, cm 
 
1123 ± 345 
36.2 ± 3.3 
25.4 ± 2.4 
 
1173 ± 284 
36.8 ± 3.2 
25.3 ± 1.8 
 
1416 ± 219 
39.1 ± 2.0 













Δ weight until 26th day, g 200 ± 190 200 ± 170 420 ± 160 0.671 < 0.001 0.001 
Days of antibiotherapy (mean ± SD) 12 ± 11 13 ± 8 5 ± 3 0.178 0.010 < 0.001 
Days of hospitalization (mean ± SD) 58 ± 24 59 ± 21 42 ± 12 0.874 0.026 0.018 
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Multivariate linear regression of infants feeding (independent variable) and fecal microbiota of preterm infants 
at 26th postnatal day (dependent variables) adjusted for gestational age, infant’s antibiotherapy received 
within 8 days prior to fecal collection, as well as maternal adherence to MD were fitted (table 14). DHM and 
formula promoted lower amounts of total bacteria and Bifidobacterium in preterm infants at 26th postnatal 
day when adjusted for gestational age (model 1), gestational age plus perinatal antibiotherapy (model 2) and 
gestational age, perinatal antibiotherapy plus maternal adhesion to MD (model 3) (table 14). In addition, 
Firmicutes were lower in formula fed infants when adjusted for the same factors (table 14). After adjusted to 
gestational age and antibiotherapy (model 2) Firmicutes were decreased in infants fed with DHM (table 14). 
 
In order to understand how the establishment and development of intestinal microbiota of preterm infants 
were affected by the feeding types received in the 8 days preceding each fecal collection, the infants were 
grouped according to the aforementioned predominant feeding criteria. 
At 2nd postnatal day, 28 preterm infants received enteral feeding. No differences were detected on meconium 
microbiota in comparison with the remaining infants that did not received enteral feeding (Figure 14). Among 
the fed infants, no differences were also found between MOM and DHM. 
Table 14 - Association between infants feeding (independent variable) and infants’ microbiota at 26th postnatal day (dependent variables). 
 Feeding type* 
 DHM Formula 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
 β p β p β p β p β p β p 
Total Bacteria -0.556 0.023 -0.665 0.007 -0.670 0.009 -0.889 < 0.001 -0.934 < 0.001 -0.928 < 0.001 
Bacteroidetes -0.681 0.112 -0.586 0.157 -0.596 0.142 -0.339 0.375 -0.278 0.450 -0.274 0.460 
Firmicutes -0.585 0.055 -0.647 0.029 -0.551 0.070 -0.789 0.004 -0.829 0.002 -0.867 0.001 
γ-Proteobacteria 0.104 0.742 0.030 0.922 0.061 0.846 -0.438 0.121 -0.486 0.072 -0.499 0.066 
Lactobacillus -0.935 0.241 -0.995 0.231 -1.178 0.141 -0.825 0.168 -0.844 0.159 -0.741 0.210 
Bifidobacterium -2.002 0.003 -2.028 0.003 -2.005 0.004 -2.092 < 0.001 -2.109 < 0.001 -2.118 < 0.001 
Bacteroides -1.087 0.254 -0.753 0.397 -0.774 0.398 -2.044 0.130 -1.997 0.104 -1.989 0.107 
Enterococcus 0.027 0.940 0.032 0.930 -0.036 0.923 -0.085 0.789 -0.082 0.798 -0.053 0.869 
Escherichia coli 0.041 0.968 0.041 0.968 -0.436 0.667 -0.364 0.683 -0.364 0.684 -0.172 0.843 
*Reference category: MOM 
Model 1 was adjusted for gestational age; Model 2 is adjusted for gestational age and infant’s antibiotherapy received within 8 
days prior to fecal collection; Model 3 is adjusted for gestational age, infant’s antibiotherapy received within 8 days prior to fecal 
collection and maternal diet. 
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Figure 14 - Influence of enteral feed on the preterm infant meconium microbiota. 
Between the 2nd and 10th days, 34 infants were fed predominantly with MOM, 26 with DHM, 10 received a 
mixed feeding (HM) and 7 with formula. No differences were verified in infants’ microbiota at 10th day of life 
(Figure 15). Interestingly, in the group that received formula Bacteroides was not detected (Figure 15c). 
Figure 15 - Preterm infant microbiota at 10th postnatal day according to feeding type. 
From the 10th and 18th day of life, formula fed infants (n = 9) presented a lower amount of total bacteria in 
comparison with MOM (n = 48) and HM (n = 6) groups (p = 0.011 and p = 0.019. respectively) (Figure 16a). 
Also, the formula group infants showed a decreased amount of Firmicutes (p = 0.028) and Bacteroides (p = 
0.049) regarding the MOM group infants (Figure 16b, c). 
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Figure 16 - Preterm infant microbiota at 18th postnatal day according to feeding type. *differences in relation to MOM. 
It was between the 18th and 26th days of age that infant feeding had the greatest influence on preterm 
microbiota. During these period, 45 preterm infants were fed mainly with MOM, 7 received DHM, 4 HM and 
17 infant formula. Because of the low number of fecal sample in the DHM and HM groups, preterm infants fed 
with MOM, DHM and HM were grouped in the same group – global-HM (Figure 17). Compared to global-HM 
infants, infants fed predominantly with formula showed lower amount of total bacteria and decreased 
Firmicutes (p = 0.034), Bacteroidetes (p = 0.005), Lactobacillus (p = 0.018), Bifidobacterium (p = 0.001) and 
Bacteroides (p = 0.017) (Figure 17a, b and c). 
Figure 17 - Preterm infants’ microbiota at 26th postnatal day according to feeding type. † Differences in relation to HM group 
(MOM + DHM).  




The first 1000 days of life – the period from conception to 2 years old – are described as a critical window of 
opportunity to a healthy growth and development [131]. Understanding the role of intrauterine environment 
on fetal microbiota, as well as the impact of very early postnatal factors on infants’ microbiota, is essential for 
bacterial modulation through clinical interventions such as maternal diet, exposure to antibiotic, probiotics 
and prebiotics, or even fecal transplantation. 
Meconium is a biological material formed during the gestation and has been considered a very useful source 
of information that reflects the in utero microbial environment [132]. Furthermore, the meconium sample 
collection is a non-invasive procedure making it a great candidate for routine clinical diagnostic practice [132]. 
The identification of specific bacteria in meconium samples provides individual-specific information to 
modulate the gut microbiota in order to promote health and reduce the chronic disease in adult life. Specially 
among the preterm infants, where it is observed a delay and immature gut microbiota, higher levels of 
oxidative stress and inflammation [133], they surely would benefit from these interventions. 
In preterm infants’ meconium, 80 to 100% of the samples presented bacterial colonized [134,135]. In this 
cohort of 117 infants born before 32 gestational weeks, 88% of meconium samples were colonized (range: 
0.790 – 5.441 log10 16S rDNA gene copies/10ng of DNA). The first pass dejection of preterm infants is known 
to have very low biomass and present technical challenges [136]. Moreover, the results of these non-
detections may be related to the detection limit of the equipment. The meconium analysis requires special 
attention. A study that collected meconium samples of healthy full-term infants within the first two hours of 
life showed that the samples that were immediately processed after collection had significantly less bacterial 
counts than samples that were stored for 4 days [47]. Nevertheless, all samples were colonized, being 
supportive of the in utero colonization hypothesis. 
Meconium microbiota of preterm infants is characterized by less diversity and by altered intestinal colonization 
of commensal bacteria with persistent dominance of facultative anaerobic bacteria (Enterobacteriaceae and 
Enterococcus, from Proteobacteria and Firmicutes phylum, respectively) [134,137]. This imbalanced 
colonization causes a delay in the subsequent establishment of strict anaerobic bacteria, such as 
Bifidobacterium and Bacteroides [137–139]. Accordingly, in this study it was observed that γ-Proteobacteria 
and Firmicutes were the dominant bacterial groups in meconium and fecal samples, but meconium also 
showed higher levels of Bifidobacterium and Bacteroides than Enterococcus. However, the prevalence of 
Bifidobacterium in meconium samples were lower than Enterococcus. Several infants hosted Bifidobacterium 
also at the 10th postnatal day, and at the 18th day Bifidobacterium was not detected in two babies. The absence 
of Bifidobacterium was also detected in a study with 29 extremely premature infants [140]. During the study 
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period, the amount of Enterococcus increased significantly, making it the dominant genera at the 18th and 26th 
postnatal days. 
Despite the high variation of microbiota composition between preterm infants, generally, they present a lower 
bacterial diversity during the first 3 months of life with dominance of Proteobacteria followed by Firmicutes 
[77,137]. At family level, Enterobacteriaceae, Clostridium and Enterococcus were identified as the most 
dominant [141,142]. Furthermore, the abundance of Bifidobacterium and Lactobacillus were lower at 2nd and 
4th postnatal weeks [140,141], as observed in this study. Also, Bacteroides were reported to be lower in 
preterm than term infants during the first 3 months [76]. In the present study, Bacteroides were absent in 35-
55% of fecal samples suggesting that preterm infants are not able to keep strict anaerobic bacteria [143].  
The dominance of potentially pathogenic bacteria (Enterobacteriaceae and Clostridium species) rather than 
commensal bacteria (Bifidobacterium, Propionibacterium, Bacteroides) as observed in infants prematurely 
delivered (table 2 ), is associated with an increased risk of postnatal complications [79,83]. Bifidobacterium, as 
Bacteroides, have important saccharoclastic characteristics to metabolize HMOs providing anti-inflammatory 
properties to the infants [69,144]. On the other hand, the Gram-negative Enterobacteriaceae are a family of 
facultative anaerobic bacteria with proinflammatory characteristics associated to NEC development. LPS on 
the outer leaflet of the Enterobacteriaceae outer membrane is recognized by TLR-4 causing inflammation. In 
addition, it is known that Enterobacteriaceae species use products of the host inflammatory response as 
source of energy to growth and to compete with other gut bacteria [79]. 
It has been reported that mothers may be responsible for the transference of these microbes to the fetus, as 
well as their metabolites and other molecules that shape the offspring’s innate immune system. In this cohort, 
35 mother-infant pairs showed a positive correlation of Firmicutes and γ-Proteobacteria right after birth. It is 
during the last trimester of pregnancy that the fetus swallows large quantities of amniotic fluid [58], which 
may be indicative of more maternal bacterial content in meconium in infants born in this gestational period. 
In agreement with this, it was found that infants delivered during the third trimester (born with more than 28 
gestational weeks) presented stronger correlations with their mothers, suggesting the hematogenous 
bacterial translocation (Figure 3b). Despite the evidence of vertical transference of microbes in infants 
prematurely delivered is very scare, a recent study with term infants concluded that vertical microbial 
transmission is a physiological process and even though infants present many microbial strains that maternal 
microbiota cannot explain, exists strong evidence of microbial transmission from multiple maternal sources to 
infants [145].  
Opposing to what was observed between mothers and their corresponding infants born by vaginal delivery, 
bacterial correlations were stronger on preterm infants delivered by C-section. The vaginal microbiota is 
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known to be different from gut microbiota being dominated by Lactobacillus species [10]. Passaging through 
the vaginal canal promoted a distinct colonization that may have mitigated the effect of vertical microbial 
transmission during pregnancy. However, these differences were not detected possibly due to the restrict 
number of bacteria analyzed in this study. In fact, in this study the mode of delivery did not show a large effect 
on preterm microbiota, since E. coli was the only bacteria found to be statistically different between vaginal 
and C-section after birth. An effect that disappeared over time. The effect of mode of delivery in the infants’ 
microbiota is contradictory [70,135]. In preterm infants, it was reported that Bacteroides were higher in vaginal 
delivery [76,146,147]. The presence of strict anaerobic bacteria (such as Bacteroides) may be indicative of the 
consumed available oxygen by facultative anaerobic and, consequently, of a faster intestinal development in 
infants born prematurely via vaginal delivery. Furthermore, it was observed that at the age of one month, 
preterm C-section delivered infants (n = 57) had more Clostridium cluster I associated with NEC (bacteria that 
were not analyzed in this study). However, the number of preterm infants born by vaginal delivered analyzed 
was low (n = 9) [71]. Recently, it was reviewed that contrary to term infants, being born either by vaginal 
delivery or C-section does not appear to affect the gut microbiota of preterm infants [83].  
The dominance of Lactobacillus in vaginal microbiota is essential to produce lactic acid and, consequently, to 
maintain a low vaginal pH preventing dysbiosis and infection that could reach the fetus [148]. The vaginal 
microbiota is dynamic and changes based on gestational age [149]. Vaginal introitus and midvaginal samples 
collected between 24th and 28th gestational weeks showed greater richness and diversity than samples 
collected between 28th and 32nd weeks [149]. So, according to the theory of vaginal bacteria ascension (Figure 
3b), it is possible to speculate that more Lactobacillus reach the fetus in 24th-28th than 28th-32nd weeks of 
gestation. In line with this, in this thesis it was observed that extremely preterm infants (born before 28 weeks) 
had more Lactobacillus compared to very preterm infants (born between 28 and 32 gestational weeks), 
suggesting the vertical ascension of bacteria from vaginal microbiota to placental/ amniotic fluid. All together, 
these findings suggest the premise that maternal bacteria from gut and vagina play a role in shaping the infants 
gut microbiota. However, the question remains open: do these bacteria reach the fetus alive, only in fragments 
or in both forms? 
The rupture of fetal membranes showed a stronger influence on microbiota of preterm infants. Meconium 
from infants with fetal membrane ruptured less than 18 hours before birth had decreased Lactobacillus and 
increased levels of E. coli. On the other hand, infants with membrane ruptured over 18 hours presented 
decreased amount of total bacteria and Firmicutes when compared to intrapartum ruptured membranes. 
Vaginal dysbiosis in mothers with lower levels of Lactobacillus and increased bacterial diversity was reported 
as a risk factor for premature membrane rupture and preterm births [150]. After the rupture of fetal 
membranes, the fetus remains without the protection that it provided. Exposed to maternal vaginal bacteria, 
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the fetus could be at higher risk of infection. The decreased levels of total bacteria, Firmicutes and Lactobacillus 
observed in membrane ruptured over 18 hours may be due to antepartum antibiotic exposure, since all 
mothers whose membranes ruptured for more 18 hours received antibiotics, as well as 16 out of 22 with 
ruptured membranes for less than 18 hours. 
As observed in this thesis, maternal antibiotherapy during gestation was reported to impact on both mother 
and offspring gut microbiota [76]. Antibiotic administration during pregnancy and/or early after birth are 
reported to increases risk of asthma, overweight and obesity in childhood (7-12 years of age) [50]. Maternal 
administration of antibiotics have been reported to reduce the infection, namely chorioamnionitis. 
Chorioamnionitis, an intra-amniotic infection that causes inflammation of the fetal membranes, is associated 
with preterm labor. In this cohort, only 6 mothers were identified with chorioamnionitis (one with intrapartum 
ruptured membranes, four with ruptured membranes and the other is not specified in the clinical records). Of 
these, only four mothers-infants pairs had their feces collected. Due to the small number of women with 
chorioamnionitis it was not possible to analyze this relation. 
Other antepartum factors, such as maternal diet, gestational diabetes and obesity, are reported to promote 
offspring chronic diseases through alterations in microbiota during the gestation period [151]. The 
(patho)physiological mechanisms by which maternal antepartum factors affect the offspring health are not 
well understood [151]. Diabetes and obesity, as well as pregnancy per se, lead to a greater intestinal 
permeability that may be regulated by gut microbiota through regulation of intracellular tight junctions. A brief 
and simplified explanation of the mechanism by which diabetes and/or obesity may alter the health status of 
mothers-and-child is demonstrated in Figure 18. 
Figure 18 - Simplified mechanism by which maternal factors (gestational diabetes, obesity, increased gestational weight gain 
and high fat diet) may alter microbiota, inflammation and glucose metabolism. This dysbiosis may be directly transmitted to the 
offspring causing an impairment in development. Image adapted from Soderborg et al, 2016 [58] and Singh et al, 2017 [153]. 
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The association between gestational diabetes and offspring health has been described. A follow-up study that 
recruited newborns at birth to 3 years of age, found that gestational diabetes was significantly associated with 
atopic dermatitis and allergen sensitization in term-delivered infants, but not in preterm infants [152]. Recent 
studies showed that diabetes during pregnancy can alter the microbiota of both woman and child in a similar 
pattern [153,154]. In 20 term newborns whose mother had gestational diabetes lower Proteobacteria and 
Actinobacteria and more Bacteroidetes were observed [153]. Furthermore, Prevotella and Lactobacillus genus 
were decreased [153]. Contrarily, Lactobacillus were found significantly more abundant in term infants 
delivered by mothers with gestational diabetes [154]. Short and long-term effects of gestational diabetes on 
microbiota of preterm infants are very scarce. Here, it was observed that Lactobacillus was decreased on 
infants born to mothers who had diabetes during pregnancy. This effect was also observed in preterm infants 
from obese mothers. Despite the low number of obese mothers in this study (n = 8), being obese was related 
to gestational diabetes status, as observed in other study [155]. However, some studies did not found 
associations between maternal obesity and gestational diabetes [152,156]. 
In fact, higher BMI categories were not only related to gestational diabetes, but also to the incidence of 
preeclampsia, gestational hypertension, antenatal admissions and preterm birth  [155]. The incidence of 
preterm infants was also found higher in underweight women [155]. In addition, maternal gut microbiota is 
related to their BMI and weight gain during pregnancy  [157]. Overweight women showed a reduced amount 
of Bifidobacterium and Bacteroidetes and increased Staphylococcus, Enterobacteriaceae and E. coli, compared 
to normal weigh mothers [157]. In this thesis, pre-gestational BMI did not showed differences on mothers’ 
fecal microbiota. However, in preterm infants it was possible to see the effect of maternal BMI. While no 
differences were found in meconium microbiota of infants delivered by women with normal weight or 
overweight, obese mothers delivered infants with significantly lower Lactobacillus and higher amount of 
Firmicutes and Bifidobacterium than normal weight group. A study with 42 Finnish women (26 normal weight 
and 16 overweight/obese) found differences in infants microbiota at 1 and 6 postnatal months [158].  The 
overall amount of Bifidobacterium species were higher in infants with normal weight than overweight/obese 
(BMI > 25 kg/m2) mothers. However, infants born from obese mothers had increased levels of Bifidobacterium 
adolescentis than normal weight group [158]. The authors discussed that Bifidobacterium adolescentis has 
been associated with inflammatory effects, contrarily to others Bifidobacterium species, such as 
Bifidobacterium longum and Bifidobacterium bifidum [158]. It would be interesting to do a deeper analysis of 
Bifidobacterium bacteria in the fecal samples of the current study, in order to determine what species could 
explain the increased levels of Bifidobacterium on infants born to obese women. 
Maternal diet, namely MD, has reported to protective against the development of diseases in adults and 
children [66]. MD also showed to be a crucial player to healthy pregnancy outcomes and prevention of 
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premature birth [64,66,159]. In addition, a single-center prospective study composed by 82 women who 
delivered preterm infants found that low MD adherence increased the risk of intrauterine growth restriction, 
low weight at birth, bronchopulmonary dysplasia and NEC [160]. However, in a study with 728 women, no 
associations between MD adherence during pregnancy and the risk of premature delivery and fetal growth 
restriction were observed [161]. Regarding the gut microbiota, MD was reported to promote greater levels of 
Lactobacillus, Bifidobacterium, Eubacteria, Bacteroides, Prevotella and increased levels of fecal SCFAs [162]. 
Based on the literature search, no studies were found on maternal adherence to MD and its effects on preterm 
infants’ gut microbiota. In this study, no effects were observed of MD adherence or nutrients intake on the 
preterm infants’ or mothers’ microbiota. It is important to note that almost all mothers with gestational 
diabetes were being followed by nutritionist and their answers may have been influenced, causing a higher 
PREDIMED score that may not have corresponded to what occurred during pregnancy. Furthermore, during 
the hospitalization of preterm infants, period in which fecal samples were collected, mothers were under 
stress as well as antibiotics – factors that are known to strongly influence intestinal microbiota. 
Finally, increasing data suggest the infant feeding significantly influences the preterm infants’ development as 
well as their microbiota composition [107]. In this cohort, preterm infants fed predominantly with formula 
showed an increased weigh gain during the first 26th days of life. At first glance, it seems that formula promoted 
a greater development and growth of preterm infants when compared to MOM or DHM. However, this may 
be because MOM and DHM were preferably administrated to immature preterm infants with less birth weight, 
length and cephalic perimeter, explaining why these infants gained less weight during the study period and 
had more days of antibiotic therapy.  Actually, differences in the gut microbiota of infants fed with MOM, DHM 
or formula could support this. The present findings also demonstrate that infant feeding takes time to 
influence the gut microbiota of preterm infants (between the 18th and 26th day of life), as seen in others studies 
[71,163]. Infant feeding significantly influenced the preterm microbiota composition. Differences in the 
amount of total bacteria and Bifidobacterium were found in infant fed with MOM, which had a higher content 
than DHM and formula. Nevertheless, these differences were lower in DHM than formula fed infants. 
DHM seemed to be more advantageous than formula in what regards benefic bacterial species. Actually, as 
can be seen in Figure 13, DHM promoted a gut microbiota with closer resemblance to MOM than to formula. 
A recent study with 69 preterm infants showed that despite the large differences between MOM (n = 34) and 
DHM-fed infants (n = 28), a similar profile was found in these groups compared to formula (n = 7) [114]. The 
dissimilarities between MOM and DHM may be due to the authors’ criteria for grouping infants – at least 80% 
of DHM in the total feedings [114]. That infants had less influence of MOM in the DHM group than in the 
present study. Gregory et al. (2016) found that DHM resembled MOM-like microbiota but only in infants 
delivered after 28 gestational week of age, but not in infants born prior to 28 weeks [111]. The authors 
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discussed that gestational age and, consequently, gut immaturity may delay the final microbiota composition. 
Actually, a follow-up study showed that preterm-delivered infants at 2 years old had lower abundance of 
Lactobacillus compared to age-matched term infants, suggesting that prematurity could be a long-lasting 
effect [164].  
Similar effects of DHM in relation to MOM on the intestinal microbiota may be related to the composition of 
HMOs, despite different total amount and relative composition of HMOs in DHM [101]. Furthermore, bacterial 
cells present in milk, even in dead or inactive form by heat treatment, may have an important role in immune 
system of these infants and in their microbial colonization. It is known that heat treatment, such as 
pasteurization, can inactive probiotic strains [165]. These non-viable microbial cells, designed as 
paraprobiotics (or ghost probiotics), have been reported to have immunomodulatory effects similar to living 
microorganisms (probiotics) [165]. 
On the other hand, formula fed-infants promote a distinct microbiota profile in relation to MOM [107]. 
However, exist a lack of congruence between the studies. Here, formula promoted lower levels of 
Bifidobacterium and Bacteroides when compared to MOM. These findings suggest that formula delays 
colonization of anaerobic bacteria and, most likely, intestinal maturation. This is an expected result since 
Bifidobacterium and Bacteroides species utilize HMOs that are absent in formula, unlike MOM and DHM. 
Despite the GOS and FOS content of formula, previous studies showed that these do not resemble the 
oligosaccharides from HM [108]. In this study, no infant in the formula group was exclusively formula-fed and 
always received some MOM or DHM. A very recent study divided 62 preterm infants into 5 groups: MOM 
exclusively fed infants (n = 7); predominantly formula exclusively fed (n = 8); mixed with ≥ 70% MOM and 
formula (n = 16); mixed with ≥ 70% formula and MOM (n = 16); and, mixed with 50% MOM and formula (n = 
15) [166]. E. coli was always increased in all feedings containing formula and infants fed with 70% formula 
presented more amount of Escherichia, Salmonella, Enterococcus and Enterobacteriaceae [166]. These results 
suggest that even a mixed fed with at least 50% formula promote a different microbiota colonization in 
preterm infants. 
Compared to term infants, preterm newborns presented an immature gastrointestinal tract with reduced 
gastric proteolytic enzymes, increased gastric pH, and decreased epithelial membrane tight junctions, 
diminished intestinal mucus coat and a microbiota low in abundance and in diversity (Figure 19a) [110,167]. 
Increasing evidence support that human milk can modify these factors creating a protection against the 
development of NEC or late-onset sepsis (Figure 19b) [110].  
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Figure 19 – Preterm infant’s intestine. a. intestine of preterm infants is immature, present an imbalanced microbiota profile and 
it is highly susceptible for disease. b. human milk provide protection against immature gut and development of diseases. Image 
adapted from Maffei and Schanle, 2017 [111]. 
The results presented in this thesis, showed that MOM is the best type of infant feeding in the promotion of 
the maturation of preterm infants’ gut microbiota, in concordance with other studies [107]. In a cohort of 45 
breastfed premature infants it was observed that preterm infants progressed to a Bifidobacterium-dominated 
microbiota after 30 weeks postmenstrual age, even when infants born by C-section [75]. These “healthier” 
microbiota is characteristic of term infants and it is associated with better health outcomes. The authors 
concluded that normal-like microbiota development is possible in hospitalized preterm infants’ delivery by C-
section if breastmilk is administrated [75]. 
Studies including preterm infants’ microbiota and their mothers’ microbiota are very scare, since this is a 
particularly vulnerable study population that presents many challenges to work with. The main limitations of 
this study are related to fecal sample collections. Due to the high workload of the NICU nursing team, and also 
to the lack of daily fecal dejections of infants, several samples were collected over time, which caused loss of 
fecal samples. Furthermore, the collection of fecal samples from mothers was very irregular and did not 
respect a specific period of days due to physiological and/or emotional reasons. In addition, health related 
information, such as smoking, BMI was not accessible in several enrolled subjects due to the lack of 
information in clinical records. Exposure to probiotics and antibiotics during gestation was not questioned. 
Even so, the present study highlights the importance of the infant feeding, and other factors, on 117 preterm 
infants’ gut microbiota.  




Preterm births are the leading cause of mortality among children under five worldwide [80]. The FEEDMI study 
confirms that preterm infant is highly affect by infant feeding, emphasizing the importance of HM. MOM 
promoted a healthier gut microbiota with higher levels of total bacteria and anaerobic bacteria 
(Bifidobacterium) compared to DHM and formula. Combining DHM and MOM into the same feeding could be 
a good strategy to prolonging HM feeding and delaying (or even suspending) formula administration in 
hospitalized preterm infants when their mothers’ milk is not sufficient. Unfortunately, DHM milk is not enough 
for all preterm infants. Actually, in Portugal, only 2 out of 40 NICUs have DHM available from the only HM bank 
at MAC. HM donation should be promoted not only by health professionals, but also by the government, as 
well as the development and implementation of HM banks in the remaining NICUs. Pasteurization techniques 
should be optimized for minimal loss of nutritional and biological components while maintaining 
microbiological safety. 
This thesis also provide evidence that antepartum factors affect gut microbiota composition of infants 
prematurely-delivered. Among the findings that almost all meconium samples were colonized, it cannot be 
discarded that infants’ meconium may have bacterial DNA prior to birth. This highlights the relevance of 
maternal microbiota transmission. Furthermore, maternal obesity was associated to gestational diabetes 
development and that influenced the gut microbiota of the infants and their mothers. Factors closely related 
to preterm birth, such as premature fetal membrane rupture and maternal antibiotic prior to birth, also 
showed an impact in infants’ microbiota. 
Altogether, these results suggest that preterm infants’ gut microbiota are highly susceptible to maternal, 
environmental and therapeutic factors. Future studies are warranted to analyze the influence of HM (MOM 
and DHM before and after pasteurization) bacteria composition on the preterm infants’ gut microbial 
acquisition. Follow-up studies assessing the microbiota evolution of preterm infants are very scare. 
Understanding how the factors mentioned above affect the long-term development, growth and microbiota 
of preterm infants is essential, since pregnancy and early life are critical window of opportunity for provide 
effective interventions for nutritional and immunomodulatory programming. To address this need, the 
FEEDMI cohort may be the primary step to initiate the first prospective follow-up study about gut microbiota 
evolution in infants in Portugal.  
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